Form D · Biotechnology
CariCord, Inc.
Aurora, CO · CIK 0001595518
Offering snapshot reported Apr 3, 2018 · SEC filing
- Reported sold
- $290K Offering amount: $1.25M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- Mar 21, 2018 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 3, 2018 | Initial | $289,609 | No comparison | 2 | SEC filing |
| Oct 13, 2015 | Initial | $100,000 | No comparison | 1 | SEC filing |
| Jul 15, 2014 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Apr 17, 2014 | Amendment | $450,000 | $0vs Mar 27, 2014 | 18 | SEC filing |
| Mar 27, 2014 | Initial | $450,000 | No comparison | 18 | SEC filing |
Offering details
- Securities
- Debt
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-309240
Source: Form D, filed Apr 3, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Gregory Andrews | Director |
| Max Brandt | Executive |
| Calvin Cole | Director, Executive |
| Brian Freed | Director |
| John Gabriel | Director, Executive |
| Tate Hermanson | Director |
| Harry Kloor | Director |
| Brian Mcenroe | Executive |
| Brian M. Mc Enroe | Director |
| James Todd | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
12635 E. Montview Blvd. Suite 142
Aurora, CO, 80045
Aurora, CO, 80045